Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06418971 · ClinicalTrials.gov registry record · NA

Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.

A NA study of Dementia and Caregiver Burden, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06418971: Recruiting NA study of Dementia and Caregiver Burden, sponsored by University of Southern California.

NCT06418971 is a NA study of Dementia and Caregiver Burden that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 80 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06418971, a NA study of Dementia and Caregiver Burden, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers of persons with dementia designed to alleviate stress and promote psychosocial well being. The main aims of this study are: * To evaluate the feasibility and acceptability of the CarePair mobile application. * To explore the potential for CarePair to reduce feelings of depression and burden, and improve caregivers' feelings of self-efficacy. Caregiver participants will be asked to log in and use the CarePair application and complete study activities for a six-week duration. Researchers will compare the intervention group to an attention control comparator to see if application use is associated with improved psychosocial outcomes at follow-up.

Primary Outcome

The feasibility of the CarePair study will be measured by the proportion of family caregivers who complete the study screening survey among those who were directly invited to participate the study.

Interventions

  • BEHAVIORAL CarePair

Study Locations (1)

California

  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-09-15
Est. Completion 2026-07-31
Phase NA
University of Southern California

617 total trials

What NCT06418971 shows while recruiting

NCT06418971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which CarePair is the first listed.

NCT06418971 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06418971 about?

NCT06418971 is a clinical study titled "Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.". The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers of persons with dementia designed to alleviate stress and promote psychosocial well being. The main aims of this study are: * To evaluate the f...

What is the current status of trial NCT06418971?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-09-15. Estimated completion is 2026-07-31.

What conditions does trial NCT06418971 study?

This clinical trial studies the following conditions: Dementia, Caregiver Burden, Caregiver Burnout.

What interventions are being tested in trial NCT06418971?

The interventions under investigation include: CarePair (BEHAVIORAL).

Who is sponsoring clinical trial NCT06418971?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06418971 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06418971's enrollment target sits among peer trials

80 129th of 199 higher than 69 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06418971, the US trial registry maintained by the National Library of Medicine. NCT06418971 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.